|
|
|
|
|
News, Reviews, and Articles on Hemorrhagic Fevers
NexBio(R) Presents DAS181 (Fludase(R)*) Potently Inhibits Novel Swine-Origin A(H1N1) and NAI-Resistant Influenza Viruses, at ICAAC 2009 Sep 14, 2009
ViradinTM, invented and developed by NexBio, is a parenteral protein under development, currently at lead optimization stage, directed to the treatment of viral hemorrhagic fevers and bacterial biothreat sepsis. TOSAPTM is a technology invented and developed by NexBio and is used to formulate DAS181 for inhalation, as well as to make nano/microparticles from virtually any type of molecule. (PR Newswire)
What's in a cough? 20,000 viruses May 13, 2009
Infective dosesBut as a guide, previous research has found that it takes just one to 10 organisms to cause viral hemorrhagic fevers, and 10 to 100 organisms to cause viral encephalitis. Tang said an infective dose of flu virus would depend on a variety of factors, such as the constitution of people breathing in these droplets and whether they had been vaccinated. (MSNBC -- Health)
Outbreaks vs. Epidemics Apr 28, 2009
When someone has been exposed to diphtheria, infectious tuberculosis, yellow fever, viral hemorrhagic fevers, SARS, and a new strain of influenza with pandemic potential. That's the federal government's list, which changes only by executive order; states may have their own. (Slate)
[ Terms Of Use | Privacy | About ]
©1998-2006 SurfWax, Inc.
All rights reserved. Patents pending.
|
|
|
Copyright SurfWax, Inc. 2006
|
|